| Literature DB >> 32921922 |
Aleksandra Duda-Chodak1, Marcin Lukasiewicz1, Gabriela Zięć1, Adam Florkiewicz1, Agnieszka Filipiak-Florkiewicz1.
Abstract
BACKGROUND: COVID-19 is a pandemic disease that has paralyzed social life and the economy around the world since the end of 2019, and which has so far killed nearly 600,000 people. The rapidity of its spread and the lack of detailed research on the course and methods of transmission significantly impede both its eradication and prevention. SCOPE AND APPROACH: Due to the high transmission rate and fatality resulting from COVID-19 disease, the paper focuses on analyzing the current state of knowledge about SARS-CoV-2 as well as its potential connection with food as a source of pathogen and infection. KEY FINDINGS ANDEntities:
Keywords: COVID-19; Food safety; Prevention; Virus transmission
Year: 2020 PMID: 32921922 PMCID: PMC7480472 DOI: 10.1016/j.tifs.2020.08.020
Source DB: PubMed Journal: Trends Food Sci Technol ISSN: 0924-2244 Impact factor: 12.563
Fig. 1Spread of coronavirus around the world from February 2020. (A) Regional pread of disease and (B) Evolution of cases and deaths [based on (Coronavirus Disease (COVID-2019) Situation Report -173, 2020)].
Fig. 2The structure of SARS-CoV-2 on the basis of (Mousavizadeh & Ghasemi, 2020; Shang et al., 2020; The Enemy Within, 2020.; Wang, Xia, et al., 2020). (A) The structure of a SARS-CoV-2 particle. (B) A scheme of the structure of coronavirus spike. S1, receptor-binding subunit; S2, membrane fusion subunit; TMD, transmembrane domain; IC, intracellular tail; VE, viral envelope. The receptor binding domain (RBD) is switching between a standing-up position (u) and a lying-down position (x). FP (fusion peptide), HR1 (heptad repeat 1), and HR2 (heptad repeat 2) are structural elements in a coronavirus S2 subunit. Arrow shows the protease cleavage site.
Comparison of known human coronaviruses.
| Genus | Alphacoronavirus | Betacoronavirus | |||||
|---|---|---|---|---|---|---|---|
| Strain | HCoV-229E | HCoV-NL63 | HCoV-OC43 | HCoV-HKU1 | SARS-CoV | SARS-CoV-2 | MERS-CoV |
| Disease | mild upper respiratory | mild upper respiratory | mild upper respiratory | pneumonia | Severe acute respiratory syndrome (SARS) | Coronavirus Disease 2019 (COVID-19) | Middle East respiratory syndrome (MERS) |
| Receptor on human cells | APN | ACE2 | ASA | ASA | ACE2 | ACE2 | DPP4 |
| Tissue/organ tropism | Monocytic and granulocytic lineage; synaptic membranes of the central nervous system; intestinal, lung and kidney epithelial cells | Arterial and venous endothelium; arterial smooth muscle; small intestine, respiratory tract epithelium; alveolar monocytes and macrophages | Sub-maxillary mucin | Airway epithelium, alveolar cells | Arterial and venous endothelium; arterial smooth muscle; small intestine, respiratory tract epithelium; alveolar monocytes and macrophages | Respiratory tract epithelium; kidney, small intestine; liver and prostate; activated leukocytes | |
| Natural host/reservoir/ | bats | bats | rodents | rodents | bats | bats | bats |
| Intermediate host | dromedary camels, alpacas | palm civets | cattle | mice | palm civets, raccoon dog | pangolin, bats | dromedary camels |
| Symptoms | Malaise, headache, nasal discharge, sneezing, sore throat, fever, cough | Cough, Rhinorrhea, tachypnea, fever, hypoxia, croup | Malaise, headache, nasal discharge, sneezing, sore throat, fever, cough | Fever, running nose, cough, dyspnea | Fever, myalgia, headache, malaise, dry cough, dyspnea, respiratory distress, diarrhea | Fever, dry cough, dyspnea, myalgia, headache, diarrhea, fatigue, shortness of breath, sore throat, nausea, vomiting, rhinorrhea, conjunctivitis | Fever, cough, chills, sore throat, myalgia, arthralgia, dyspnea, pneumonia, diarrhea and vomiting, acute renal impairment |
| Transmission | Respiratory droplets, fomites | Respiratory droplets, fomites | Respiratory droplets, fomites | Respiratory droplets, fomites | Respiratory droplets, fomites, fecal-oral | Respiratory droplets, fomites, fecal-oral | Respiratory droplets, fomites |
| Transmission by asymptomatic patient | not reported | not reported | not reported | not reported | very rare | often | no |
| References | ( | ( | ( | ( | ( | ( | ( |
APN – aminopeptidase N, ACE2 – angiotensin-converting enzyme 2, DPP4 – dipeptidyl peptidase 4, ASA – 9-O-acetylated sialic a.
Fig. 3The possible routes of SARS-CoV-2 entry into the target cell: pathway ‘a' – through a direct fusion on the cellular surface, pathway ‘b' – via endocytosis (on the basis of (The Enemy Within, 2020)).
Fig. 4Possible routes of SARS-CoV-2 evolution [based on ( Zhang, Yang, et al., 2020)].
Fig. 5Transmission routes involving direct contact, indirect contact by contaminated surfaces and fomites, as well as by droplets (short range) and droplet nuclei (long range) spreading [on the basis of (Tang et al., 2006)].